Related by context. Frequent words. (Click for all words.) 61 monovalent 60 SCH # 59 VLP vaccine 59 Immunogenicity 58 conjugate vaccine 58 immunomodulator 57 adjuvanted 57 administered subcutaneously 56 label multicenter 56 Cyclosporine 56 Irinotecan 56 synthetic peptide 56 phase IIb 55 nab paclitaxel 55 intravenously administered 55 Phase 1b clinical 55 serogroups 55 Phase 1b trial 55 Trastuzumab 55 thymalfasin 55 CYC# 55 Azedra 54 Pivotal Phase III 54 orally bioavailable 54 HspE7 54 AIDSVAX 54 ZOSTAVAX 54 trivalent 54 Completes Enrollment 54 integrase inhibitor 54 Pegasys R 54 phase IIa 54 prospective randomized controlled 54 anti CD# antibody 54 immunogenicity 54 HER2/neu 54 randomized Phase III 54 Phase Ia 54 Pivotal Trial 53 active comparator 53 HCV protease inhibitor 53 Pivotal Phase 53 Adjuvant 53 GRN#L 53 Ribavirin 53 immunomodulators 53 nitazoxanide 53 multicenter clinical 53 ROTATEQ 53 dose escalation trial 53 Taxotere ® 53 dose limiting toxicities 53 Adenovirus 53 Chlamydia trachomatis 53 Phase 1a 53 Lenalidomide 53 Phase 2a trial 53 Randomized Controlled Trial 53 monoclonal antibody 52 single ascending dose 52 Influenza Vaccine 52 VLPs 52 adjuvant 52 pharmacodynamics 52 double blinded placebo 52 decitabine 52 placebo controlled clinical 52 recombinant vaccine 52 Bortezomib 52 Carboplatin 52 microgram dose 52 dose escalation study 52 immunotherapeutic 52 immunogenic 52 tipranavir 52 xenograft models 52 raltegravir 51 Monotherapy 51 HGS ETR1 51 Gemcitabine 51 tanespimycin 51 LY# [002] 51 antibody 51 Clinical Study 51 Phase IIa trial 51 ISENTRESS 51 IMGN# 51 safety tolerability pharmacokinetics 51 Menveo 51 valopicitabine 51 Phase Ib 51 interferon alfa 51 immunomodulatory 51 mAbs 51 multicenter randomized double 51 recombinant protein 51 Reolysin 51 antiviral activity 51 nanoemulsion 51 dose cohorts 50 Phase 2a clinical